Prof. Dr. De-Kui Zhang is a distinguished gastroenterologist and Principal Investigator recognized for his extensive research in Helicobacter pylori infection, inflammatory bowel disease (IBD), gastrointestinal motility disorders, and behavioral gastroenterology. He received advanced academic training in clinical gastroenterology and molecular pathogenesis, progressing to a leading research and academic role in China. With over h-index of 19, 1345 citations, and 116 total documents, he has significantly shaped current understanding of host–pathogen interactions and chronic microbial infection. He has including four NSFC grants, advancing molecular models of microbial pathogenesis and contributing to clinical diagnostic innovations. His scholarly contributions include co-editing the academic volume Health Management of Gastritis, while his leadership roles in national academic committees—particularly within the Helicobacter pylori Group of the Chinese Society of Gastroenterology—underscore his influence on clinical guidelines and national research priorities. His work has been recognized with prestigious distinctions such as the Gansu Provincial Scientific Progress Second Prize, highlighting his impact on improving digestive health outcomes. Prof. Zhang continues to mentor emerging medical scientists and strengthen national collaborations, contributing broadly to translational gastroenterology research and patient care advancement.
Ma, X., Li, M., Wang, X., Xu, H., Jiang, L., Wu, F., Wei, L., Qi, G., & Zhang, D. (2024). Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway. International Immunopharmacology.
Liu, N., Luo, Q., Gou, L., Shen, X., & Zhang, D. (2024). Knowledge and practices of Helicobacter pylori infection management among physicians in Gansu Province, China: A cross-sectional study. Helicobacter.
Gou, L., Yang, X., Yun, J., Ma, Z., Zheng, X., Du, H., & Zhang, D. (2024). Roles of the components of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori. Future Microbiology. Advance online publication.
Ma, X., Li, J., Li, M., Qi, G., Wei, L., & Zhang, D. (2024). NETs in fibrosis: Bridging innate immunity and tissue remodeling. International Immunopharmacology.
Xu, H., Huang, K., Shi, M., Gong, H., Han, M., Tian, W., Wang, X., & Zhang, D. (2024). MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application. Pharmacological Research,